Consolidated Statement of Changes in Equity (IFRS)

 

Share capitalShare premium accountTreasury sharesInvested unrestricted equityOther reservesTranslation differencesRetained earningsTotal
SHAREHOLDERS' EQUITY Jan 1, 20183,5281,187-841111,131592-11,2298,920113,289
Effect of IFRS 9 restatement - bad debt provision      -128-128
Effect of IFRS 2 amendment      1,0431,043
SHAREHOLDERS' EQUITY Jan 1, 2018 (restated)3,5281,187-841111,131592-11,2299,835114,204
Comprehensive income     1,096-7,079-5,983
Share based payments  204-204  2,2292,229
Cash flow hedges    240  240
Defined benefit plans     25759
SHAREHOLDERS' EQUITY Dec 31, 20183,5281,187-638110,928832-10,1315,042110,749

 

 

Share capitalShare premium accountTreasury sharesInvested unrestricted equityOther reservesTranslation differencesRetained earningsTotal
SHAREHOLDERS' EQUITY Jan 1, 20173,5281,187-1,043111,333540-4,86322,182132,864
Effect of IFRS 15 restatement to revenue     86-2,495-2,409
SHAREHOLDERS’ EQUITY Jan 1, 2017 (restated)3,5281,187-1,043111,333540-4,77619,687130,455
Effect of IFRS15 restatements to revenue      77
Comprehensive income     -6,451-11,531-17,982
Share based payments  202-202  602602
Adjustment to previous years    52  52
Defined benefit plans      155155
SHAREHOLDERS' EQUITY Dec 31, 20173,5281,187-841111,131592-11,2288,920113,289

 

Powered by Socool CMS.